Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QL1706 Plus Endocrine Therapy in HR+/HER2- Breast Cancer With Poor Response to Neoadjuvant Chemotherapy
NCT07782840Phase 2Not yet recruiting
- Sponsor
- The Fourth Hospital of Hebei Medical University
- Start
- Oct 2026
- Primary completion
- Jun 2028
01
Overview
A Phase 2 trial of QL1706 in breast cancer, sponsored by The Fourth Hospital of Hebei Medical University. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
QL1706
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT07782840.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07782840.